Table 3.
Disease prevalence of 199 chronic conditions: number of patients treated, prevalence rate (per 1000), age and gender (per cent within gender) of all conditions and chosen medicine for Denmark at 1 January 2013
| No. | Name of condition | ICD-10 code/definition | Number and prevalence | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Denmark | Men | Age 16–44 (per 1000) | Age 45–74 (per 1000) | Age 75+ (per 1000) | |||||
| N | Per 1000 (standardised) | Per cent | |||||||
| B—Viral hepatitis and human immunodeficiency virus [HIV] disease | B18, B20–B24 | 8813 | 1.9 | (2.0) | 65.3 | 1.8 | 2.4 | 0.3 | |
| 1 | Chronic viral hepatitis | B18 | 4584 | 1.0 | (1.0) | 60.1 | 1.0 | 1.2 | 0.1 |
| 2 | Human immunodeficiency virus [HIV] disease | B20–24 | 4229 | 0.9 | (0.9) | 71.0 | 0.8 | 1.2 | 0.1 |
| C—Malignant neoplasms | C00–C99; D32–D33; D35.2–D35.4; D42–D44 | 229,331 | 50.3 | (50.4) | 43.3 | 10.2 | 69.4 | 155.8 | |
| 3 | Malignant neoplasms of other and unspecified localizations | C00–C14; C30–C33; C37–C42; C45–C49; C69; C73–74; C754–C759 | 20,557 | 4.5 | (4.6) | 53.5 | 1.3 | 6.6 | 10.1 |
| 4 | Malignant neoplasms of digestive organs | C15–C17; C22–C26 | 4839 | 1.1 | (1.1) | 59.5 | 0.1 | 1.6 | 3.4 |
| 5 | Malignant neoplasm of colon | C18 | 18,826 | 4.1 | (4.1) | 47.0 | 0.2 | 4.9 | 20.3 |
| 6 | Malignant neoplasms of rectosigmoid junction, rectum, anus and anal canal | C19–C21 | 10,680 | 2.3 | (2.3) | 55.4 | 0.1 | 3.2 | 9.5 |
| 7 | Malignant neoplasm of bronchus and lung | C34 | 14,762 | 3.2 | (3.3) | 49.4 | 0.2 | 4.8 | 10.6 |
| 8 | Malignant melanoma of skin | C43 | 19,636 | 4.3 | (4.3) | 42.6 | 2.0 | 5.7 | 9.0 |
| 9 | Other malignant neoplasms of skin | C44 | 15,597 | 3.4 | (3.4) | 51.2 | 0.3 | 3.9 | 16.7 |
| 10 | Malignant neoplasm of breast | C50 | 50,687 | 11.1 | (11.1) | 0.7 | 1.0 | 17.6 | 29.5 |
| 11 | Malignant neoplasms of female genital organs | C51–C52; C56–C58 | 7245 | 1.6 | (1.6) | – | 0.3 | 2.4 | 3.9 |
| 12 | Malignant neoplasm of cervix uteri, corpus uteri and part unspecified | C53–C55 | 11,608 | 2.5 | (2.5) | 0.0 | 0.7 | 3.5 | 7.1 |
| 13 | Malignant tumour of male genitalia | C60, C62–C63 | 5194 | 1.1 | (1.1) | 99.9 | 1.2 | 1.2 | 0.7 |
| 14 | Malignant neoplasm of prostate | C61 | 26,697 | 5.9 | (5.9) | 100.0 | 0.0 | 7.5 | 27.0 |
| 15 | Malignant neoplasms of urinary tract | C64–C68 | 10,319 | 2.3 | (2.3) | 71.2 | 0.1 | 2.9 | 9.9 |
| 16 | Brain cancerc | C71, C75.1–C75.3, D33.0–D33.2, D35.2–D35.4, D43.0–D43.2, D44.3–D44.5 (brain). C70, D32, D42 (brain membrane). C72, D33.3–D33.9, D43.3–D43.9 (cranial nerve, spinal cord) | 15,310 | 3.4 | (3.4) | 52.9 | 1.4 | 4.7 | 6.2 |
| 17 | Malignant neoplasms of ill-defined, secondary and unspecified sites, and of independent (primary) multiple sites | C76–C80, C97 | 25,619 | 5.6 | (5.6) | 43.0 | 1.2 | 8.4 | 14.0 |
| 18 | Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | C81–C96 | 19,712 | 4.3 | (4.3) | 54.4 | 1.5 | 5.6 | 12.4 |
| D—In situ and benign neoplasms, and neoplasms of uncertain or unknown behaviour and diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | D00–D09; D55–D59; D60–D67; D80–D89 | 116,560 | 25.6 | (25.7) | 36.3 | 13.2 | 27.3 | 80.1 | |
| 19 | In situ neoplasms | D00–D09 | 19,810 | 4.3 | (4.4) | 20.0 | 2.5 | 5.5 | 7.9 |
| 20 | Haemolytic anaemias | D55–D59 | 3055 | 0.7 | (0.7) | 33.7 | 0.7 | 0.6 | 1.2 |
| 21 | Aplastic and other anaemias | D60–D63 | 14,918 | 3.3 | (3.3) | 40.2 | 0.9 | 3.3 | 15.0 |
| 22 | Other anaemias | D64 | 46,613 | 10.2 | (10.3) | 38.7 | 2.3 | 9.7 | 53.1 |
| 23 | Coagulation defects, purpura and other haemorrhagic conditions | D65–D69 | 25,376 | 5.6 | (5.6) | 37.4 | 5.2 | 5.7 | 7.1 |
| 24 | Other diseases of blood and blood-forming organs | D70–D77 | 8896 | 2.0 | (2.0) | 43.5 | 1.0 | 2.6 | 3.6 |
| 25 | Certain disorders involving the immune mechanism | D80–D89 | 7660 | 1.7 | (1.7) | 50.8 | 1.4 | 2.0 | 1.3 |
| E—Endocrine, nutritional and metabolic diseases | E00–E14; E20–E29; E31–35; E70–E78; E84–E85; E88–E89 | 877,433 | 192.6 | (192.7) | 45.6 | 43.5 | 279.6 | 501.4 | |
| 26 | Diseases of the thyroidc | E00–E04, E06, E07 | 131,908 | 29.0 | (29.0) | 15.9 | 11.3 | 39.1 | 66.2 |
| 27 | Thyrotoxicosisc | E05 | 41,374 | 9.1 | (9.0) | 18.3 | 3.8 | 10.8 | 26.7 |
| 28 | Diabetes type 1c | E10 | 23,062 | 5.1 | (5.1) | 57.9 | 4.9 | 5.6 | 3.5 |
| 29 | Diabetes type 2c | E11 | 242,177 | 53.2 | (53.3) | 53.0 | 8.5 | 77.9 | 152.1 |
| 30 | Diabetes othersc | E12–E14 | 1117 | 0.2 | (0.2) | 48.6 | 0.2 | 0.3 | 0.5 |
| 31 | Disorders of other endocrine glands | E20–E35, except E30 | 28,650 | 6.3 | (6.4) | 28.6 | 6.5 | 5.6 | 8.9 |
| 32 | Metabolic disorders | E70–E77; E79–E83; E85, E88–E89; | 23,690 | 5.2 | (5.2) | 36.6 | 3.7 | 6.1 | 8.2 |
| 33 | Disturbances in lipoprotein circulation and other lipidsc | E78 | 652,242 | 143.2 | (143.1) | 51.1 | 11.8 | 221.2 | 408.1 |
| 34 | Cystic fibrosisc | E84 | 947 | 0.2 | (0.2) | 41.9 | 0.3 | 0.1 | 0.1 |
| G—Diseases of the nervous system | G00–G14; G20–G32; G35–G37; G40–47; G50–64; G70–73; G80–G83; G90–G99 | 561,054 | 123.2 | (123.5) | 40.1 | 70.6 | 162.2 | 188.6 | |
| 35 | Inflammatory diseases of the central nervous system | G00–G09 | 7642 | 1.7 | (1.7) | 50.1 | 1.3 | 2.0 | 2.2 |
| 36 | Systemic atrophies primarily affecting the central nervous system and other degenerative diseases | G10–G14, G30–G32 | 10,401 | 2.3 | (2.3) | 46.8 | 0.4 | 2.2 | 12.1 |
| 37 | Parkinson’s diseasec | G20, G21, G22, F02.3 | 57,583 | 12.6 | (12.6) | 43.7 | 4.1 | 16.3 | 37.3 |
| 38 | Extrapyramidal and movement disorders | G23–G26 | 10,837 | 2.4 | (2.4) | 41.8 | 1.1 | 2.9 | 6.4 |
| 39 | Sclerosis | G35 | 13,284 | 2.9 | (2.9) | 30.6 | 1.9 | 4.2 | 1.5 |
| 40 | Demyelinating diseases of the central nervous system | G36–G37 | 4571 | 1.0 | (1.0) | 34.7 | 0.9 | 1.3 | 0.4 |
| 41 | Epilepsyc | G40–G41 | 61,695 | 13.5 | (13.6) | 48.2 | 9.7 | 16.0 | 20.3 |
| 42 | Migrainec | G43 | 149,866 | 32.9 | (33.0) | 18.6 | 24.9 | 44.1 | 15.6 |
| 43 | Other headache syndromes | G44 | 16,469 | 3.6 | (3.6) | 35.9 | 4.0 | 3.6 | 1.8 |
| 44 | Transient cerebral ischaemic attacks and related syndromes and vascular syndromes of brain in cerebrovascular diseases | G45–G46 | 43,977 | 9.7 | (9.7) | 53.5 | 1.1 | 12.7 | 37.6 |
| 45 | Sleep disorders | G47 | 36,806 | 8.1 | (8.1) | 73.5 | 4.1 | 12.6 | 5.0 |
| 46 | Disorders of trigeminal nerve and facial nerve disorders | G50–G51 | 21,488 | 4.7 | (4.7) | 43.0 | 2.8 | 6.0 | 7.4 |
| 47 | Disorders of other cranial nerves, cranial nerve disorders in diseases classified elsewhere, nerve root and plexus disorders and nerve root and plexus compressions in diseases classified elsewhere | G52–G55 | 12,429 | 2.7 | (2.7) | 48.9 | 1.3 | 4.0 | 3.6 |
| 48 | Mononeuropathies of upper limb | G56 | 122,395 | 26.9 | (26.9) | 37.2 | 12.6 | 39.1 | 36.5 |
| 49 | Mononeuropathies of lower limb, other mononeuropathies and mononeuropathy in diseases classified elsewhere | G57–G59 | 18,627 | 4.1 | (4.1) | 43.8 | 1.9 | 6.1 | 5.0 |
| 50 | Polyneuropathies and other disorders of the peripheral nervous system | G60–G64 | 30,289 | 6.6 | (6.7) | 56.4 | 1.7 | 9.3 | 18.2 |
| 51 | Diseases of myoneural junction and muscle | G70–G73 | 5758 | 1.3 | (1.3) | 47.7 | 0.9 | 1.5 | 1.6 |
| 52 | Cerebral palsy and other paralytic syndromes | G80–G83 | 14,410 | 3.2 | (3.2) | 53.9 | 2.9 | 3.5 | 3.2 |
| 53 | Other disorders of the nervous system | G90–G99 | 44,394 | 9.7 | (9.8) | 46.4 | 5.9 | 12.1 | 17.0 |
| H—Diseases of the eye and adnexa and diseases of the ear and mastoid process | H02–H06; H17–H18; H25–H28; H31–H32; H34–H36; H40–55; H57; H80, H810; H93, H90–H93 | 448,176 | 98.4 | (98.6) | 47.5 | 25.6 | 112.6 | 394.4 | |
| 54 | Disorders of eyelid, lacrimal system and orbit | H02–H06 | 13,191 | 2.9 | (2.9) | 37.3 | 0.9 | 4.0 | 7.5 |
| 55 | Corneal scars and opacities | H17 | 2173 | 0.5 | (0.5) | 58.1 | 0.2 | 0.5 | 1.3 |
| 56 | Other disorders of cornea | H18 | 9473 | 2.1 | (2.1) | 43.5 | 1.0 | 2.1 | 7.4 |
| 57 | Diseases of the eye lens (cataracts) | H25–H28 | 68,009 | 14.9 | (15.1) | 40.5 | 0.5 | 15.6 | 84.8 |
| 58 | Disorders of the choroid and retina | H31–H32 | 1900 | 0.4 | (0.4) | 48.3 | 0.2 | 0.5 | 1.1 |
| 59 | Retinal vascular occlusions | H34 | 10,358 | 2.3 | (2.3) | 50.8 | 0.2 | 2.6 | 11.4 |
| 60 | Other retinal disorders | H35 | 68,485 | 15.0 | (15.1) | 40.2 | 1.6 | 13.0 | 93.7 |
| 61 | Retinal disorders in diseases classified elsewhere | H36 | 19,279 | 4.2 | (4.3) | 58.7 | 1.7 | 6.1 | 7.4 |
| 62 | Glaucomac | H40–H42 | 67,310 | 14.8 | (14.9) | 43.5 | 1.2 | 16.2 | 76.4 |
| 63 | Disorders of the vitreous body and globe | H43–H45 | 7572 | 1.7 | (1.7) | 44.6 | 0.7 | 2.4 | 3.1 |
| 64 | Disorders of optic nerve and visual pathways | H46–H48 | 6184 | 1.4 | (1.4) | 39.0 | 1.2 | 1.6 | 1.4 |
| 65 | Disorders of ocular muscles, binocular movement, accommodation and refraction | H49–H52 | 18,247 | 4.0 | (4.0) | 45.4 | 4.3 | 3.9 | 2.8 |
| 66 | Visual disturbances | H53 | 22,232 | 4.9 | (4.9) | 45.7 | 2.6 | 5.9 | 11.1 |
| 67 | Blindness and partial sight | H54 | 6614 | 1.5 | (1.5) | 44.4 | 0.6 | 1.5 | 5.6 |
| 68 | Nystagmus and other irregular eye movements and other disorders of eye and adnexa | H55, H57 | 11,133 | 2.4 | (2.5) | 40.3 | 1.7 | 3.0 | 3.7 |
| 69 | Otosclerosis | H80 | 10,360 | 2.3 | (2.3) | 35.7 | 0.8 | 3.1 | 5.4 |
| 70 | Ménière’s diseasec | H810 | 10,003 | 2.2 | (2.2) | 43.0 | 0.4 | 3.0 | 7.3 |
| 71 | Other diseases of the inner ear | H83 | 29,865 | 6.6 | (6.3) | 91.8 | 0.6 | 9.0 | 24.5 |
| 72 | Conductive and sensorineural hearing loss | H90 | 43,238 | 9.5 | (9.6) | 48.7 | 3.7 | 11.3 | 29.5 |
| 73 | Other hearing loss and other disorders of ear, not elsewhere classified | H910, H912, H913, H918, H930, H932, H933 | 8306 | 1.8 | (1.8) | 53.0 | 0.7 | 2.3 | 5.2 |
| 74 | Presbycusis (age-related hearing loss) | H911 | 80,659 | 17.7 | (17.6) | 48.9 | 0.4 | 9.6 | 147.4 |
| 75 | Hearing loss, unspecified | H919 | 87,806 | 19.3 | (19.3) | 55.3 | 3.0 | 24.5 | 74.5 |
| 76 | Tinnitus | H931 | 40,124 | 8.8 | (8.7) | 58.4 | 2.5 | 13.4 | 17.5 |
| 77 | Other specified disorders of ear | H938 | 20,537 | 4.5 | (4.4) | 48.1 | 0.8 | 5.9 | 16.1 |
| I—Diseases of the circulatory system | I05–I06; I10–28; I30–33;I36–141; I44–I52; I60–I88; I90–I94; I96–I99 | 1,254,427 | 275.4 | (275.5) | 45.3 | 73.3 | 381.5 | 753.9 | |
| 78 | Aortic and mitral valve diseasec | I05, I06, I34, I35 | 30,123 | 6.6 | (6.6) | 50.9 | 0.7 | 6.4 | 37.7 |
| 79 | Hypertensive diseasesc | I10–I15 | 1,060,046 | 232.7 | (232.7) | 44.6 | 41.8 | 330.8 | 695.8 |
| 80 | Heart failurec | I11.0, I13.0, I13.2, I42.0, I42.6, I42.7, I42.9, I50.0, I50.1, I50.9 | 37,540 | 8.2 | (8.3) | 63.5 | 0.7 | 9.5 | 40.3 |
| 80A | Ischaemic heart diseases | I20–I25 | 139,173 | 30.6 | (30.7) | 60.2 | 2.6 | 41.8 | 114.5 |
| 81 | Angina pectoris | I20 | 78,476 | 17.2 | (17.3) | 58.4 | 1.6 | 25.7 | 53.0 |
| 82 |
Acute myocardial infarction and subsequent myocardial infarction |
I21–I22 | 36,654 | 8.0 | (8.1) | 66.6 | 0.7 | 11.1 | 29.8 |
| 83 | AMI complex/other | I23–I24 | 2969 | 0.7 | (0.7) | 61.3 | 0.1 | 0.9 | 2.3 |
| 84 | Chronic ischaemic heart disease | I25 | 84,592 | 18.6 | (18.6) | 64.7 | 0.8 | 23.8 | 81.4 |
| 85 | Pulmonary heart disease and diseases of pulmonary circulation | I26–I28 | 15,352 | 3.4 | (3.4) | 44.8 | 1.0 | 3.8 | 13.0 |
| 86 | Acute pericarditis | I30 | 5563 | 1.2 | (1.2) | 73.1 | 1.0 | 1.4 | 1.3 |
| 87 | Other forms of heart disease | I31–I43, except I34–I35 and I42 | 8,119 | 1.8 | (1.8) | 60.5 | 0.7 | 2.1 | 5.4 |
| 88 | Atrioventricular and left bundle branch block | I44 | 14,604 | 3.2 | (3.2) | 58.7 | 0.4 | 2.7 | 20.0 |
| 89 | Other conduction disorders | I45–46 | 11,823 | 2.6 | (2.6) | 59.6 | 1.0 | 2.8 | 9.5 |
| 90 | Paroxysmal tachycardia | I47 | 39,510 | 8.7 | (8.7) | 48.1 | 3.3 | 11.0 | 23.9 |
| 91 | Atrial fibrillation and flutter | I48 | 112,342 | 24.7 | (24.7) | 57.2 | 1.7 | 26.5 | 132.0 |
| 92 | Other cardiac arrhythmias | I49 | 34,418 | 7.6 | (7.6) | 47.9 | 2.2 | 8.7 | 28.8 |
| 93 | Complications and ill-defined descriptions of heart disease and other heart disorders in diseases classified elsewhere | I51–52 | 7337 | 1.6 | (1.6) | 50.3 | 0.6 | 1.8 | 5.7 |
| 94 | Stroke | I60, I61,I63–I64, Z501 (rehabilitation) | 72,606 | 15.9 | (16.0) | 54.2 | 1.6 | 19.8 | 68.7 |
| 95 | Cerebrovascular diseases | I62, I65–I68 | 17,308 | 3.8 | (3.8) | 51.1 | 0.8 | 4.9 | 13.3 |
| 96 | Sequelae of cerebrovascular disease | I69 | 50,952 | 11.2 | (11.2) | 52.5 | 0.8 | 12.7 | 55.9 |
| 97 | Atherosclerosis | I70 | 32,064 | 7.0 | (7.0) | 53.6 | 0.4 | 8.3 | 34.2 |
| 98 | Aortic aneurysm and aortic dissection | I71 | 10,296 | 2.3 | (2.3) | 72.2 | 0.1 | 2.6 | 11.2 |
| 99 | Diseases of arteries, arterioles and capillaries | I72, I74, I77–I79 | 11,830 | 2.6 | (2.6) | 45.6 | 1.0 | 3.4 | 6.2 |
| 100 | Other peripheral vascular diseases | I73 | 28,508 | 6.3 | (6.3) | 54.8 | 0.7 | 8.3 | 24.4 |
| 101 | Phlebitis, thrombosis of the portal vein and others | I80–I82 | 37,388 | 8.2 | (8.3) | 45.5 | 3.5 | 10.2 | 22.2 |
| 102 | Varicose veins of lower extremities | I83 | 23,530 | 5.2 | (5.2) | 30.6 | 3.2 | 6.8 | 6.6 |
| 103 | Haemorrhoidsc | I84 | 74,285 | 16.3 | (16.3) | 40.1 | 14.5 | 17.5 | 19.0 |
| 104 | Oesophageal varices (chronic), varicose veins of other sites, other disorders of veins, non-specific lymphadenitis, other non-infective disorders of lymphatic vessels and lymph nodes and other and unspecified disorders of the circulatory system | I85–I99, except I89 and I95 | 15,194 | 3.3 | (3.3) | 52.6 | 2.2 | 3.9 | 6.1 |
| J—Diseases of the respiratory system | J30.1; J40–J47; J60–J84; J95, J97–J99 | 1,210,598 | 265.7 | (266.3) | 42.1 | 209.3 | 298.8 | 381.9 | |
| 105 | Respiratory allergyc | J30, except J30.0 | 841,685 | 184.8 | (185.2) | 41.0 | 154.0 | 204.3 | 240.3 |
| 105A | Chronic lower respiratory diseasesc | J40–J43, J47 | 418,120 | 91.8 | (92.0) | 39.8 | 57.8 | 112.8 | 156.3 |
| 106 |
Bronchitis, not specified as acute or chronic, simple and mucopurulent chronic bronchitis and unspecified chronic bronchitis |
J40–J42 | 12,790 | 2.8 | (2.8) | 43.6 | 0.4 | 3.5 | 11.3 |
| 107 | Emphysema | J43 | 5557 | 1.2 | (1.2) | 51.1 | 0.2 | 1.7 | 3.7 |
| 108 | Chronic obstructive lung disease (COPD)c | J44, J96, J13–J18 | 216,184 | 47.5 | (47.6) | 45.0 | 17.6 | 60.6 | 131.4 |
| 109 | Asthma, status asthmaticusc | J45–J46 | 361,129 | 79.3 | (79.4) | 42.1 | 64.2 | 86.5 | 118.4 |
| 110 | Bronchiectasis | J47 | 4362 | 1.0 | (1.0) | 35.0 | 0.3 | 1.4 | 2.2 |
| 111 | Other diseases of the respiratory system | J60–J84; J95, J97–J99 | 21,993 | 4.8 | (4.9) | 52.5 | 1.5 | 6.2 | 14.6 |
| K—Diseases of the digestive system | K25–K27; K40, K43, K50–52; K58–K59; K71–K77; K86–K87 | 329,337 | 72.3 | (72.6) | 44.7 | 41.3 | 86.3 | 157.4 | |
| 112 | Ulcersc | K25–K27 | 157,379 | 34.5 | (34.8) | 43.2 | 15.3 | 42.4 | 91.9 |
| 113 | Inguinal hernia | K40 | 25,032 | 5.5 | (5.5) | 88.7 | 2.1 | 7.7 | 11.5 |
| 114 | Ventral hernia | K43 | 7941 | 1.7 | (1.7) | 44.7 | 0.7 | 2.5 | 3.3 |
| 115 | Crohn’s diease | K50 | 18,913 | 4.2 | (4.2) | 41.4 | 4.4 | 4.1 | 3.4 |
| 116 | Ulcerative colitis | K51 | 29,538 | 6.5 | (6.5) | 45.2 | 5.4 | 7.2 | 8.2 |
| 117 | Other non-infective gastroenteritis and colitis | K52 | 20,844 | 4.6 | (4.6) | 35.5 | 2.6 | 5.0 | 12.8 |
| 118 | Irritable bowel syndrome (IBS) | K58 | 37,593 | 8.3 | (8.3) | 29.9 | 7.5 | 9.0 | 8.4 |
| 119 | Other functional intestinal disorders | K59 | 51,933 | 11.4 | (11.5) | 37.0 | 6.5 | 11.8 | 34.1 |
| 120 | Diseases of liver, biliary tract and pancreas | K71–K77; K86–K87 | 26,956 | 5.9 | (6.0) | 48.6 | 2.4 | 8.8 | 8.5 |
| L—Diseases of the skin and subcutaneous tissue | L40 | 65,469 | 14.4 | (14.5) | 47.8 | 7.9 | 19.3 | 21.7 | |
| 121 | Psoriasisc | L40 | 65,469 | 14.4 | (14.5) | 47.8 | 7.9 | 19.3 | 21.7 |
| M—Diseases of the musculoskeletal system and connective tissue | M01–M25; M30–M36; M40–M54; M60.1–M99 | 1,032,808 | 226.7 | (227.1) | 42.2 | 113.2 | 291.2 | 470.5 | |
| 122 | Infectious arthropathies | M01–M03 | 9402 | 2.1 | (2.1) | 49.7 | 1.8 | 2.3 | 2.1 |
| 122A | Inflammatory polyarthropathies and ankylosing spondylitisc | M05–M14, M45 | 165,944 | 36.4 | (36.5) | 51.7 | 12.7 | 50.4 | 84.9 |
| 123 | Rheumatoid arthritisc | M05, M06, M07.1, M07.2, M07.3, M08, M09 | 77,345 | 17.0 | (17.0) | 34.2 | 8.1 | 23.1 | 30.5 |
| 124 |
Inflammatory polyarthropathies – except rheumatoid arthritisc |
M074–M079, M10–M14, M45 | 115,945 | 25.5 | (25.5) | 58.3 | 7.9 | 35.4 | 63.3 |
| 125 | Polyarthrosis [arthrosis] | M15 | 16,935 | 3.7 | (3.7) | 20.8 | 0.2 | 5.4 | 12.6 |
| 126 | Coxarthrosis [arthrosis of hip] | M16 | 104,115 | 22.9 | (22.7) | 43.3 | 2.0 | 26.8 | 108.1 |
| 127 | Gonarthrosis [arthrosis of knee] | M17 | 178,811 | 39.3 | (39.4) | 44.2 | 5.0 | 58.6 | 113.5 |
| 128 | Arthrosis of first carpometacarpal joint and other arthrosis | M18–M19 | 91,101 | 20.0 | (20.1) | 41.7 | 4.2 | 31.0 | 43.4 |
| 129 | Acquired deformities of fingers and toes | M20 | 55,730 | 12.2 | (12.3) | 21.3 | 5.5 | 17.9 | 17.1 |
| 130 | Other acquired deformities of limbs | M21 | 20,584 | 4.5 | (4.5) | 34.9 | 2.7 | 5.8 | 6.9 |
| 131 | Disorders of patella (knee cap) | M22 | 38,999 | 8.6 | (8.6) | 38.0 | 13.7 | 5.0 | 0.6 |
| 132 | Internal derangement of knee | M230, M231, M233, M235, M236, M238 | 9192 | 2.0 | (2.0) | 55.6 | 2.8 | 1.5 | 0.4 |
| 133 | Derangement of meniscus due to old tear or injury | M232 | 36,374 | 8.0 | (8.0) | 53.6 | 6.9 | 10.2 | 2.5 |
| 134 | Internal derangement of knee, unspecified | M239 | 28,206 | 6.2 | (6.2) | 50.0 | 6.9 | 6.3 | 2.3 |
| 135 | Other specific joint derangements | M24, except M240–M241 | 5923 | 1.3 | (1.3) | 57.2 | 1.9 | 0.9 | 0.5 |
| 136 | Other joint disorders, not elsewhere classified | M25 | 12,043 | 2.6 | (2.7) | 34.7 | 2.3 | 3.1 | 1.9 |
| 137 | Systemic connective tissue disorders | M30–M36, except M32,M34 | 42,631 | 9.4 | (9.4) | 24.7 | 4.2 | 10.0 | 32.3 |
| 138 | Systemic lupus erythematosus | M32 | 3376 | 0.7 | (0.7) | 12.9 | 0.5 | 1.0 | 0.7 |
| 139 | Dermatopolymyositis | M33 | 1137 | 0.2 | (0.2) | 39.8 | 0.1 | 0.4 | 0.4 |
| 140 | Systemic sclerosis | M34 | 1675 | 0.4 | (0.4) | 21.0 | 0.1 | 0.6 | 0.5 |
| 141 | Kyphosis, lordosis | M40 | 4160 | 0.9 | (0.9) | 47.7 | 0.7 | 1.1 | 0.7 |
| 142 | Scoliosis | M41 | 17,686 | 3.9 | (3.9) | 31.9 | 5.0 | 2.7 | 4.3 |
| 143 | Spinal osteochondrosis | M42 | 8034 | 1.8 | (1.8) | 63.4 | 1.4 | 2.2 | 1.0 |
| 144 | Other deforming dorsopathies | M43 | 23,756 | 5.2 | (5.3) | 42.4 | 2.2 | 7.3 | 9.9 |
| 145 | Other inflammatory spondylopathies | M46 | 7086 | 1.6 | (1.6) | 45.5 | 1.1 | 1.9 | 2.0 |
| 146 | Spondylosis | M47 | 61,999 | 13.6 | (13.6) | 45.9 | 2.4 | 21.2 | 31.4 |
| 147 | Other spondylopathies and spondylopathies in diseases classified elsewhere | M48, M49 | 50,805 | 11.2 | (11.2) | 44.8 | 1.1 | 14.7 | 43.7 |
| 148 | Cervical disc disorders | M50 | 11,476 | 2.5 | (2.5) | 46.4 | 1.5 | 3.8 | 1.2 |
| 149 | Other intervertebral disc disorders | M51 | 40,161 | 8.8 | (8.9) | 49.4 | 6.4 | 11.4 | 7.6 |
| 150 | Other dorsopathies, not elsewhere classified | M53 | 7246 | 1.6 | (1.6) | 40.9 | 1.4 | 1.9 | 1.2 |
| 151 | Dorsalgia | M54 | 40,780 | 9.0 | (9.0) | 42.9 | 7.3 | 10.0 | 11.9 |
| 152 | Soft tissue disorders | M60–M63, except M60.0 | 13,422 | 2.9 | (3.0) | 28.6 | 3.2 | 2.8 | 2.4 |
| 153 | Synovitis and tenosynovitis | M65 | 19,104 | 4.2 | (4.2) | 37.5 | 3.1 | 5.4 | 3.8 |
| 154 | Disorders of synovium and tendon | M66–68 | 19,669 | 4.3 | (4.3) | 41.7 | 4.7 | 4.3 | 2.1 |
| 155 | Soft tissue disorders related to use, overuse and pressure | M70 | 11,090 | 2.4 | (2.4) | 42.4 | 1.6 | 3.0 | 3.4 |
| 156 | Fibroblastic disorders | M72 | 43,600 | 9.6 | (9.6) | 63.7 | 2.3 | 14.2 | 22.6 |
| 157 | Shoulder lesions | M75 | 58,112 | 12.8 | (12.7) | 50.3 | 7.2 | 19.0 | 8.6 |
| 158 | Enthesopathies of lower limb, excluding foot | M76 | 11,223 | 2.5 | (2.5) | 49.4 | 2.7 | 2.6 | 0.9 |
| 159 | Other enthesopathies | M77 | 10,500 | 2.3 | (2.3) | 40.4 | 1.9 | 2.9 | 1.0 |
| 160 | Rheumatism, unspecified | M790 | 6852 | 1.5 | (1.5) | 13.7 | 0.7 | 2.3 | 1.2 |
| 161 | Myalgia | M791 | 10,168 | 2.2 | (2.2) | 36.8 | 1.4 | 2.9 | 3.0 |
| 162 | Other soft tissue disorders, not elsewhere classified | M792– M794; M798–M799 | 7939 | 1.7 | (1.7) | 36.9 | 1.5 | 2.0 | 1.7 |
| 163 | Other soft tissue disorders, not elsewhere classified: pain in limb | M796 | 22,201 | 4.9 | (4.9) | 41.5 | 3.9 | 5.5 | 6.7 |
| 164 | Fibromyalgia | M797 | 3399 | 0.7 | (0.7) | 4.5 | 0.6 | 1.0 | 0.3 |
| 165 | Osteoporosisc | M80–M81 | 158,813 | 34.9 | (34.8) | 15.3 | 0.7 | 43.5 | 163.6 |
| 166 | Osteoporosis in diseases classified elsewhere | M82 | 1007 | 0.2 | (0.2) | 35.2 | 0.1 | 0.3 | 0.7 |
| 167 | Adult osteomalacia and other disorders of bone density and structure | M83, M85, except M833 | 43,271 | 9.5 | (9.5) | 19.2 | 1.9 | 14.4 | 22.7 |
| 168 | Disorders of continuity of bone | M84 | 1865 | 0.4 | (0.4) | 51.6 | 0.3 | 0.5 | 0.5 |
| 169 | Other osteopathies | M86–M90 | 24,251 | 5.3 | (5.3) | 38.4 | 2.2 | 7.0 | 12.4 |
| 170 | Other disorders of the musculoskeletal system and connective tissue | M95–M99 | 30,038 | 6.6 | (6.6) | 52.1 | 5.4 | 7.4 | 8.2 |
| N—Diseases of the genitourinary system | N18 | 20,162 | 4.4 | (4.5) | 59.4 | 1.0 | 4.8 | 20.0 | |
| 171 | Chronic renal failure (CRF)c | N18 | 20,162 | 4.4 | (4.5) | 59.4 | 1.0 | 4.8 | 20.0 |
| Q—Congenital malformations, deformations and chromosomal abnormalities | Q00–Q56; Q60–Q99 | 124,898 | 27.4 | (27.5) | 41.7 | 33.9 | 23.2 | 16.2 | |
| 172 | Congenital malformations: of the nervous, circulatory and respiratory systems, cleft palate and cleft lip, urinary tract, bones and muscles, other and chromosomal abnormalities not elsewhere classified | Q00–Q07; Q20–Q37; Q60–Q99 | 85,534 | 18.8 | (18.9) | 37.8 | 23.7 | 15.6 | 9.8 |
| 173 | Congenital malformations of eye, ear, face and neck | Q10–Q18 | 19,689 | 4.3 | (4.3) | 38.8 | 6.2 | 3.0 | 1.8 |
| 174 | Other congenital malformations of the digestive system | Q38–Q45 | 6481 | 1.4 | (1.4) | 41.8 | 1.0 | 1.6 | 2.9 |
| 175 | Congenital malformations of the sexual organs | Q50–Q56 | 16,192 | 3.6 | (3.6) | 64.3 | 4.1 | 3.3 | 1.9 |
| F—Mental and behavioural disorders | F00–99 | 683,194 | 150.0 | (150.7) | 41.0 | 135.2 | 150.2 | 223.7 | |
| 176 | Dementiac | F00, G30, F01, F02.0, F03.9, G31.8B, G31.8E, G31.9, G31.0B | 36,803 | 8.1 | (8.1) | 36.3 | 0.0 | 3.7 | 71.7 |
| 177 | Organic, including symptomatic, mental disorders | F04–F09 | 26,430 | 5.8 | (5.9) | 48.8 | 2.5 | 5.8 | 22.6 |
| 178 | Mental and behavioural disorders due to use of alcohol | F10 | 59,143 | 13.0 | (13.2) | 67.0 | 9.4 | 17.5 | 7.9 |
| 179 | Mental and behavioural disorders due to psychoactive substance use | F11–F19 | 53,669 | 11.8 | (11.9) | 54.2 | 13.3 | 11.2 | 7.2 |
| 180 | Schizophreniac | F20 | 29,422 | 6.5 | (6.5) | 58.2 | 7.1 | 6.6 | 2.2 |
| 181 | Schizotypal and delusional disorders | F21–F29 | 39,694 | 8.7 | (8.8) | 50.3 | 9.2 | 8.7 | 6.2 |
| 182 | Bipolar affective disorderc | F30–F31 | 22,669 | 5.0 | (5.0) | 40.6 | 3.6 | 6.2 | 5.7 |
| 183 | Depressionc | F32, F33, F34.1, F06.32 | 454,933 | 99.9 | (100.2) | 35.5 | 79.1 | 107.5 | 165.8 |
| 184 | Mood (affective) disorders | F340, F348–F349, F38–F39 | 6887 | 1.5 | (1.5) | 35.9 | 1.3 | 1.6 | 1.7 |
| 185 | Phobic anxiety disorders | F40 | 14,324 | 3.1 | (3.2) | 33.4 | 5.0 | 1.9 | 0.3 |
| 186 | Other anxiety disorders | F41 | 38,079 | 8.4 | (8.4) | 32.6 | 10.0 | 7.3 | 5.3 |
| 187 | Obsessive compulsive disorder (OCD)c | F42 | 10,062 | 2.2 | (2.2) | 36.7 | 3.8 | 1.0 | 0.5 |
| 188 | Post-traumatic stress disorder | F431 | 16,055 | 3.5 | (3.6) | 48.6 | 3.9 | 3.8 | 0.4 |
| 189 | Reactions to severe stress and adjustment disorders | F432–F439 | 61,701 | 13.5 | (13.7) | 39.1 | 18.6 | 10.4 | 4.4 |
| 190 | Dissociative (conversion) disorders, somatoform disorders and other neurotic disorders | F44, F45, F48 | 21,420 | 4.7 | (4.7) | 31.7 | 4.6 | 5.2 | 3.1 |
| 191 | Eating disorders | F50 | 7751 | 1.7 | (1.7) | 5.2 | 3.5 | 0.3 | 0.1 |
| 192 | Behavioural syndromes associated with physiological disturbances and physical factors | F51–F59 | 6163 | 1.4 | (1.3) | 46.3 | 1.9 | 1.0 | 0.3 |
| 193 | Emotionally unstable personality disorder | F603 | 21,848 | 4.8 | (4.9) | 21.2 | 7.7 | 2.8 | 0.2 |
| 194 | Specific personality disorders | F602, F604–F609 | 50,415 | 11.1 | (11.2) | 39.3 | 14.4 | 9.4 | 2.7 |
| 195 | Disorders of adult personality and behaviour | F61–F69 | 17,533 | 3.8 | (3.9) | 44.3 | 5.0 | 3.3 | 0.7 |
| 196 | Mental retardation | F70–F79 | 13,822 | 3.0 | (3.1) | 53.9 | 3.8 | 2.6 | 1.2 |
| 197 | Disorders of psychological development | F80–F89 | 9911 | 2.2 | (2.2) | 65.4 | 4.1 | 0.6 | 0.3 |
| 198 | Hyperkinetic disorders (ADHD)c | F90 | 42,908 | 9.4 | (9.5) | 60.6 | 17.1 | 3.5 | 1.0 |
| 199 | Behavioural and emotional disorders with onset usually occurring in childhood and adolescence | F91–F99 | 39,602 | 8.7 | (8.8) | 48.3 | 11.8 | 6.6 | 3.7 |
| Having one or more chronic conditions | 2,989,441 | 656.2 | (657.2) | 45.5 | 480.5 | 771.5 | 953.9 | ||
Standardised rates in brackets
See table with 10-year age intervals in Supplementary Material 2 in the electronic supplementary material
Conditions marked ‘A’, overlap with other conditions and are thus not counted twice [44]
ICD-10 International Statistical Classification of Diseases, 10th Revision
c Complex defined conditions; see reference for further details [44]
** 2-year prevalence